Uzm. Dr. Hatice Ayyıldız Sevim
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Colorectal Neoplasms 2 publicationsSource: OpenAlex / PubMed MeSHView publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- Department name at the sourceOnkolojisaglik.gov.trFrom source
- InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
- Area of workColorectal NeoplasmsExtracted from 2 publications · Model version —From source
- Publications17 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-4072-5861ORCIDFrom source
- Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#hatice-ayyildiz-sevimsaglik.gov.tr
Scientific work
Publications on Colorectal Neoplasms
-
Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab
Medicina, 2026
DOI 10.3390/medicina62081459 PMID 42654356 Open-access full textSource: OpenAlex
-
Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor–Targeted Therapies: A Prospective Cross-Sectional Real-World Study
Medicina, 2026
DOI 10.3390/medicina62061175 PMID 42356187 Open-access full textSource: OpenAlex
-
Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size
BMC Cancer, 2026
DOI 10.1186/s12885-026-15598-y PMID 41555284 Open-access full textSource: OpenAlex
-
Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study
Current Oncology, 2026
DOI 10.3390/curroncol33090526 PMID 42782872 Open-access full textSource: OpenAlex
-
Quality of Life and Patient-Reported Outcomes During First-Line Chemotherapy in Older Patients with De Novo Metastatic Gastrointestinal Cancers: A Prospective Longitudinal Study
Healthcare, 2026
DOI 10.3390/healthcare14203458 PMID 42940505 Open-access full textSource: ORCID
-
Prognostic and Treatment-Context Associations of EASIX and IPI in Extensive-Stage Small-Cell Lung Cancer Patients Receiving First-Line Therapy
Cancers, 2026
DOI 10.3390/cancers18172888 PMID 42738408 Open-access full textSource: ORCID
-
Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching
Current Oncology, 2026
DOI 10.3390/curroncol33080467 PMID 42645372 Open-access full textSource: ORCID
-
C-Reactive Protein–Albumin–Lymphocyte Index and the Modified Glasgow Prognostic Score as Predictors of Early Mortality After Palliative Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15124608 PMID 42355776 Open-access full textSource: ORCID
-
Concomitant Metformin Use During Nivolumab Therapy for Advanced Non-Small Cell Lung Cancer: A Real-World Analysis of Survival Outcomes
Acta haematologica oncologica Turcica., 2026
DOI 10.4274/ahot.galenos.2026.2026-7-6 Open-access full textSource: OpenAlex
-
Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy
Discover Oncology, 2026
DOI 10.1007/s12672-026-04938-w PMID 41979751 Open-access full textSource: OpenAlex